$AMTX Income Statement | Understand Stock

$AMTX

$1.26 -$0.04 (3.08%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Sales
Revenues
Production tax credits
Cost of goods sold
Gross loss
Research and development expenses
Selling, general and administrative expenses
Operating loss
Interest expense
Interest rate expense
Debt related fees and amortization expense
Accretion and other expenses of Series A preferred units
Loss on debt extinguishment
Gain on litigation
Other income
Loss before income taxes
Income tax benefit
Net loss
Less: Net loss attributable to non-controlling interest
Net loss attributable to Aemetis, Inc.
Foreign currency translation adjustment

Other comprehensive loss
Foreign currency translation loss
Comprehensive loss
Net loss per common share
Basic (in dollars per share)
Diluted (in dollars per share)
Weighted average shares outstanding
Basic (in shares)
Diluted (in shares)

Comments